New bladder cancer injection enters first human safety tests

NCT ID NCT05483868

Summary

This early-stage trial is testing a new drug called belzupacap sarotalocan (AU-011) for bladder cancer that hasn't spread into the muscle wall. Researchers will inject the drug directly into tumors during a standard bladder procedure to see if it's safe and practical to use. The study will enroll 55 patients to monitor side effects and gather initial information about how well the treatment might work.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UROTHELIAL CARCINOMA BLADDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Arkansas Urology

    TERMINATED

    Little Rock, Arkansas, 72211, United States

  • Austin Health

    NOT_YET_RECRUITING

    Heidelberg, Victoria, 3084, Australia

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Baylor College of Medicine

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Email: •••••@•••••

  • Carolina Urologic Research Center

    RECRUITING

    Myrtle Beach, South Carolina, 29272, United States

    Contact Email: •••••@•••••

  • Hollywood Private Hospital

    RECRUITING

    Nedlands, Washington, 6009, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Montefiore Medical Center

    RECRUITING

    The Bronx, New York, 10461, United States

    Contact Email: •••••@•••••

  • Penninsula Private Hospital

    NOT_YET_RECRUITING

    Langwarrin, Victoria, 3910, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Saint John's Cancer Institute

    RECRUITING

    Santa Monica, California, 90404, United States

    Contact Email: •••••@•••••

  • The Royal Melbourne Hospital

    NOT_YET_RECRUITING

    Parkville, Victoria, 3050, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • The University of Texas San Antonio

    RECRUITING

    San Antonio, Texas, 78229, United States

    Contact Email: •••••@•••••

  • The Urology Place

    RECRUITING

    San Antonio, Texas, 78240, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Tower Urology

    RECRUITING

    Los Angeles, California, 90048, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Urology Associates, P.C.

    SUSPENDED

    Nashville, Tennessee, 37209, United States

  • Urology Clinics of North Texas

    RECRUITING

    Dallas, Texas, 75251, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Urology San Antonio/USA Clinical Trials

    RECRUITING

    San Antonio, Texas, 78229, United States

    Contact Email: •••••@•••••

  • Warringal Private Hospital

    RECRUITING

    Heidelberg, Victoria, Australia

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Westmead Private Hospital

    RECRUITING

    Westmead, New South Wales, 2145, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.